1[1]Fujimura Y. Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans.Virchow Arch, 2000,436:560-566.
2[2]Gebert A. The role of M cells in the protection of mucosal membranes. Histochem Cell Bio, 1997, 108: 455-470.
3[3]Gebert A, Pabst R. M cells at locations outside the gut. Immunology, 1999,11:165-170.
4[4]Berguist C, Jhonason E L, Lagergard T, et al. Intranasal vaccination of humans with recombinant colera toxin B subunit induces sustemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun, 1997,65:2676-2682.
5[5]Brandtzaeg P, Farstad I N, Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today, 1999,20:267-277.
6[6]Zuercher A W, Coffin S E, Thurnheer M C, et al. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J Immunol, 2002,168:1796-1803.
7[7]Liang B, Hyland L, Hou S. Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice. J Virol, 2001, 75: 5416-5420.
8[8]Perry M,Whyte A. Immunology of the tonsils.Immunol Today,1998,19:414-421.
9[9]Porgador A, Staats H F, Itoh Y, et al. Ntranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasalmucosa-associated lymphoid tissue. Infect Immun, 1998, 66: 5876-5881.
10[10]Papadas T, Batistatou A, Ravazoula P, et al. S-100 protein-positive dendritic cells and CD34-positive dendritic interstitial cells in palatine tonsils. Eur Arch Otorhinolaryngol, 2001,258:243-245.
